However in breast cancer cells, down regulation of ferroportin promotes breast cancer growth and is correlated with poor prognosis.39 This suggests iron regulation is altered in breast cancer and could be a target for cancer therapy. This evidence concerns the gene SLC40A1 and breast cancer.